文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

美国PrEP使用者中男男性行为者性传播感染筛查的差距

Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
PubMed 文献 · Clin Infect Dis · 2021-01-01

本研究基于2017至2019年ARTnet网络调查,分析美国3259名HIV阴性MSM在PrEP护理中的STI筛查情况。结果显示,曾使用PrEP者中血液、尿液/尿道拭子、直肠拭子和咽拭子的一致筛查率分别为87%、78%、57%和64%。东南部PrEP使用者进行泌尿生殖道和直肠STI一致筛查的可能性显著低于其他地区。

要点

  • 曾用PrEP的MSM中直肠和咽部STI筛查率仅57%和64%,远低于CDC建议。
  • 东南部PrEP使用者泌尿生殖道和直肠STI筛查率显著低于其他地区。
  • 需加强直肠和咽部无症状感染的筛查,尤其在高负担的东南部地区。

核心结论

  • CDC推荐的PrEP护理中STI筛查与实际临床实践存在显著差距,直肠和咽部筛查及东南部地区尤为突出。

研究设计与样本

  • 基于2017至2019年互联网ARTnet调查数据,纳入3259名HIV阴性MSM,按当前、既往和从未使用PrEP分层。
  • 采用Poisson回归模型(稳健误差方差)分析与一致(“总是”或“有时”)暴露部位特异性STI筛查相关的因素,包括东南部居住。

主要发现

  • 3259名HIV阴性MSM中,19%当前使用PrEP,6%曾使用,75%从未使用。
  • 曾使用PrEP者中,血液、尿液/尿道拭子、直肠拭子和咽拭子的一致STI筛查率分别为87%、78%、57%和64%。

关键数值与推荐

  • CDC建议使用PrEP的MSM每3-6个月进行全面STI筛查。
  • 一致筛查定义为“总是”或“有时”进行暴露部位特异性STI筛查。

临床怎么用

  • 临床应按照CDC指南对PrEP使用者定期进行多部位STI筛查,尤其重视直肠和咽部采样。
  • 东南部地区需针对性加强PrEP护理中的STI筛查实施。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The US Centers for Disease Control and Prevention (CDC) recommends comprehensive sexually transmitted infection (STI) screening every 3-6 months for men who have sex with men (MSM) using human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). The gaps between these recommendations and clinical practice by region have not been quantified. METHODS: We used survey data collected from the internet-based ARTnet study between 2017 and 2019 on STI screening among MSM across the United States, stratified by current, prior, and never PrEP use. Poisson regression models with robust error variance were used to model factors, including residence in the Southeast, associated with consistent ("always" or "sometimes") exposure site-specific STI screening during PrEP care. RESULTS: Of 3259 HIV-negative MSM, 19% were currently using PrEP, 6% had used PrEP in the past, and 75% had never used PrEP. Among ever PrEP users, 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab, or pharyngeal swab, respectively, during PrEP care. Compared to PrEP users in all other regions, PrEP users in the Southeast were significantly less likely to be consistently screened for urogenital (adjusted prevalence ratio [aPR], 0.86; 95% confidence interval [CI], .76-.98) and rectal STIs (aPR, 0.76; 95% CI, .62-.93) during PrEP care. CONCLUSIONS: Substantial gaps exist between CDC recommendations for STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngeal exposure sites that can harbor asymptomatic infections and for MSM in Southeast states where the STI burden is substantial.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chandra C, Weiss KM, Kelley CF, et al. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States. Clin Infect Dis. 2021. PMID: 32702116. doi:10.1093/cid/ciaa1033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。